TY - JOUR
T1 - Dysregulation of GAS5–miRNA-Mediated Signaling Pathways in Cancer Pathobiology
T2 - A Comprehensive Exploration of Pathways Influenced by this Axis
AU - Oghenemaro, Enwa Felix
AU - Khaleel, Abdulrahman Qais
AU - Rizaev, Jasur Alimdjanovich
AU - Roopashree, R.
AU - Suliman, Muath
AU - Kazmi, Syeda Wajida
AU - Hjazi, Ahmed
AU - Rajput, Pranchal
AU - Mustafa, Yasser Fakri
AU - Abosaoda, Munther Kadhim
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2025/4
Y1 - 2025/4
N2 - The long non-coding RNA Growth Arrest-Specific 5 (GAS5) is pivotal in modulating key signaling pathways by functioning as a molecular sponge for microRNAs (miRNAs). GAS5 is notably recognized for its antitumor properties, primarily through its ability to sequester oncogenic miRNAs, thereby influencing critical pathways such as p53, Wnt/β-catenin, and PI3K/Akt, all of which are integral to cell proliferation, apoptosis, and metastasis. The disruption of GAS5–miRNA interactions has been implicated in various malignancies, reinforcing its potential as both a biomarker and a therapeutic target. This paper delves into the intricate signaling cascades affected by GAS5–miRNA interactions and thoroughly investigates the diagnosis and treatment prospects associated with GAS5. Moreover, it addresses both the challenges and opportunities for translational applicability of these findings in clinical environments. The study emphasizes GAS5’s significance within the cancer molecular landscape and posits that precise modulation of GAS5–miRNA interactions could catalyze transformative developments in cancer diagnostics and therapeutic approaches. This comprehensive review not only highlights the critical role of non-coding RNAs in cancer biology but also aims to lay the groundwork for future investigations aimed at harnessing these insights for therapeutic interventions.
AB - The long non-coding RNA Growth Arrest-Specific 5 (GAS5) is pivotal in modulating key signaling pathways by functioning as a molecular sponge for microRNAs (miRNAs). GAS5 is notably recognized for its antitumor properties, primarily through its ability to sequester oncogenic miRNAs, thereby influencing critical pathways such as p53, Wnt/β-catenin, and PI3K/Akt, all of which are integral to cell proliferation, apoptosis, and metastasis. The disruption of GAS5–miRNA interactions has been implicated in various malignancies, reinforcing its potential as both a biomarker and a therapeutic target. This paper delves into the intricate signaling cascades affected by GAS5–miRNA interactions and thoroughly investigates the diagnosis and treatment prospects associated with GAS5. Moreover, it addresses both the challenges and opportunities for translational applicability of these findings in clinical environments. The study emphasizes GAS5’s significance within the cancer molecular landscape and posits that precise modulation of GAS5–miRNA interactions could catalyze transformative developments in cancer diagnostics and therapeutic approaches. This comprehensive review not only highlights the critical role of non-coding RNAs in cancer biology but also aims to lay the groundwork for future investigations aimed at harnessing these insights for therapeutic interventions.
KW - GAS5
KW - Interaction
KW - lncRNA
KW - microRNA
UR - http://www.scopus.com/inward/record.url?scp=85212813460&partnerID=8YFLogxK
U2 - 10.1007/s10528-024-10997-x
DO - 10.1007/s10528-024-10997-x
M3 - Review article
C2 - 39718723
AN - SCOPUS:85212813460
SN - 0006-2928
VL - 63
SP - 1149
EP - 1175
JO - Biochemical Genetics
JF - Biochemical Genetics
IS - 2
M1 - a003236
ER -